Conditions: Arthritis, Rheumatoid
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 91
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to evaluate the long-term safety of BI 695500 in adult patients with moderately to severely active rheumatoid arthritis (RA) who have successfully completed treatment in Trial 1301.1.

Detailed description:

Arms:
arm 1: BI 695500, Two infusions separated by 2 weeks, Intravenous infusion

Interventions: intervention 1: BI 695500
Intervention descriptions: intervention 1: None

Protocol document: